We hypothesized that serum cystatin C can be a more predictable marker of arterial stiffness than serum creatinine and creatinine-based glomerular filtration rate (GFR). The aim of this study is to evaluate whether serum cystatin C is related to arterial stiffness independently of serum creatinine in subjects for whom serum creatinine is normal. A total of 2,018 individuals (1,120 males, 898 females) were enrolled. Mean brachial-ankle pulse wave velocity (baPWV) was used as a marker of arterial stiffness and sex-specific analysis 
Introduction
Cystatin C is a cysteine protease inhibitor and is a member of the human cysteine superfamily that has a function as a housekeeping gene with a stable production by most nucleated cells (1) . Also, cystatin C is a nonglycosylated 13 kDa basic protein that is filtered by the glomeruli and reabsorbed and catabolized by the tubular epithelial cells, with only small amounts excreted in the urine (2) . Because of its freely filterable size through the glomerular filtration barrier, cystatin C has been proposed as an endogenous surrogate of glomerular filtration rate (GFR) (3) . Recently, several large epidemiological studies have shown that cystatin C is a better predictor of subjects' outcomes in coronary heart disease, acute coronary syndrome, and heart failure, independently of serum creatinine (4) (5) (6) . Additionally, in type 1 diabetes, increasing serum cystatin C predicted progression of subclinical coronary atherosclerosis, even while adjusting for other cerebrovascular disease risk factors (7) . Furthermore, serum cystatin C better predicted progression of subclinical coronary atherosclerosis than serum creatinine and serum creatinine-based GFR (7) .
Arterial stiffness has been a strong independent predictor of coronary events and cardiovascular mortality in several patient groups (8) (9) (10) . Increased arterial stiffness is one of the pathological states of vascular damage and is closely associ-ated with atherosclerosis. Among several methods to evaluate the arterial stiffness, brachial-ankle pulse wave velocity (baPWV) is very easily measured and is a fairly reproducible method that correlates well with arterial stiffness determined by an invasive method (11) .
In a screened cohort, increased pulse wave velocity was associated with low creatinine clearance and proteinuria (12) . However, little data exist regarding the relationship of cystatin C to arterial stiffness in the general population. We hypothesized that serum cystatin C can be a more predictable marker of arterial stiffness than serum creatinine and creatinine-based GFR.
The aim of this study is to evaluate whether serum cystatin C is related to arterial stiffness independently of serum creatinine in subjects for whom serum creatinine is normal. 
Methods

Subjects
A total of 18,572 individuals over 18 years of age participated in a 1-d health-screening program from Jan. 2006 to Dec. 2007. Of these, 2,189 individuals underwent voluntary baPWV measurement. All enrolled subjects had no history of peripheral artery disease or aortic disease. Subjects with hyperthyroidism, hypothyroidism, liver cirrhosis and abnormal serum creatinine (male, serum creatinine ≥ 1.5 mg/dL; female, serum creatinine ≥ 1.3 mg/dL) were excluded before enrollment. Also, subjects whose ankle-brachial index was more than 1.3 and less than 0.95 were excluded to ensure the accuracy of baPWV measurement before analyses. In the final analyses, a total of 2,018 individuals (1,120 males, 898 females) were enrolled. All medical and social histories and symptoms were confirmed by the consulting doctor. This study was approved by the Ethical Committee of Pusan National University Hospital.
Laboratory Data and Measurement of baPWV
Blood pressure and heart rate were measured in a seated postition after resting for at least 10 min. The following laboratory data were obtained; urine protein level, hemoglobin, creatinine, cystatin C, uric acid, γ-glutamyltransferase (GGT), lipid profile, glucose, insulins, and C-reactive protein (CRP). Serum creatinine was measured by a modified Jaffe reaction (Modular D; Roche Diagnostics, Mannheim, Germany) and serum cystatin C was measured using the latex agglutination test (Modular P800; Roche Diagnostics). Homeostasis model assessment-insulin resistance (HOMAIR) was calculated using serum levels of fasting glucose and insulin (13) . GFR was calculated using the Abbreviated Modification of Diet in Renal Disease equation (14) . The baPWV was measured using an automatic waveform analyzer (VP-2000; Colin Co., Komaki, Japan). All individuals were examined after resting in the supine position for at least 5 min. We used the mean baPWV (mean of the right and left baPWV) as a marker of arterial stiffness and classified the baPWV into quartiles.
Statistical Analysis
All continuous variables are expressed as mean±SD and proportions are expressed as percentage. 
Results
Results of Male Subjects
The total number of males was 1,120 and the mean age was 51.7±9.2 (22-78). Mean baPWV was 1,402±243.1 cm/s and interquartile cut-off points were 1,238.8, 1,365.8 and 1,517.0 cm/s. Table 1 shows the results of the baseline characteristics in detail. Age, proportion of smoking history, and waist circumference were higher in the 4th quartile group than in the 1st and 2nd quartiles groups. Table 2 shows a comparison of the data according to baPWV quartiles. With increased baPWV, subjects had higher serum cystatin C, GGT, and triglycerides. In the 1st quartile group, serum creatinine, GFR, uric acid, total cholesterol, low-density lipoprotein (LDL) cholesterol, fasting glucose, insulin and HOMAIR were the lowest in comparison with the other quartile groups. CRP was the highest in the 4th quartile group. Univariate linear regression analysis revealed that several variables were correlated with baPWV. Table 3 shows the results for significant variables. Figure 1 shows the positive relationship between baPWV and serum cystatin C (Y= 1,109.0548 +329.9102X, r 2 = 0.056, p< 0.001). Stepwise multivariate regression analysis showed that age, waist circumference, heart rate, serum cystatin C, serum triglycerides and fasting glucose were independent contributors to baPWV (Table 4) .
Results of Female Subjects
The total number of females was 898 and mean age was 50.9±9.7 (18-84). The mean baPWV was 1,393±236.5 cm/s and the interquartile cut-off points were 1,240.0, 1,344.0 and 1,511.0 cm/s. Table 5 shows the results of the baseline characteristics in detail. All of the baseline characteristics were similar among the four quartile groups except for waist circumference. With increased baPWV, subjects had higher heart rate, serum cystatin C, serum triglycerides, fasting glucose, insulin level, and HOMAIR (Table 6 ). In the 1st quartile group, serum creatinine, GFR, and uric acid were the lowest in comparison with the other quartile groups. CRP was the highest in the 4th quartile group. Univariate linear regression analysis revealed that several variables were correlated with baPWV. However, body mass index, total cholesterol and insulin were not significantly correlated (Table 7 ). Figure 2 shows the positive relationship between baPWV and serum Stepwise multivariate regression analysis showed that age, heart rate, cystatin C level, fasting glucose, and insulin level were independent contributors to baPWV (Table 8) .
Age, heart rate, fasting glucose and serum cystatin C were the significant variables in both genders that contributed to baPWV.
Discussion
The remarkable finding of this study is that serum cystatin C is related to baPWV, a marker representing arterial stiffness, independently of serum creatinine and creatinine-based GFR.
Serum cystatin C has been proposed to reflect cumulative effects on GFR over time, to have less measurement variability, and to better estimate the slope in decline in GFR (15) . Additionally, the cystatin C assay is more precise than assays for serum creatinine, especially in the low range (16) . Recently, investigators from the Cardiovascular Health Study (17), a community-based cohort of ambulatory elderly individuals in the US, measured cystatin C and compared cystatin C and creatinine as predictors of cardiovascular disease and mortality risk over 10 years of follow up. Consequently, cystatin C had a linear association with mortality risk, while creatinine had a J-shaped association with mortality risk.
Moreover, in quintile comparison, cystatin C was associated with a significantly elevated risk of death from cardiovascular causes, myocardial infarction and stroke. Based on these results, cystatin C was a stronger predictor of the risk of death and cardiovascular events in elderly persons than creatinine. In most studies, cystatin C was used as the marker of kidney function and was superior to creatinine as a determinant of clinical outcomes. Thus, some investigators hypothesized that cystatin C may be linked to mortality by an alternative pathologic process that is distinct from its relationship to kidney function (1). For example, Shlipak et al. showed that CRP and fibrinogen levels were linearly associated with cystatin C but had a U-shaped association with creatinine and creatininebased GFR (18) . This relationship with inflammatory markers was identified in the present study (data not shown). One study suggested that cystatin had an atheroprotective effect in animal experiment (19) . However, there is no pathogenetic evidence that would link cystatin C to cardiovascular mortality other than its correlation with GFR.
Several factors can affect the serum level of cystatin C, including age, male sex, smoking, higher weight, inflammatory state, liver cirrhosis, hyperthyroidism, and hypothyroidism (20) . In the present study, subjects who had liver cirrhosis, hyperthyroidism and hypothyroidism were excluded before enrollment. Also, sex-specific analysis was performed to exclude the effect of sex on the relationship between serum level of cystatin C and baPWV.
Several lines of evidence suggest that pulse wave velocity (PWV) in patients with end-stage renal disease (ESRD) is elevated and predicts future cardiovascular disease and death (21) (22) (23) . Furthermore, in one screened cohort, increased PWV was associated with low creatinine clearance, age, systolic blood pressure, proteinuria, fasting glucose, and cholesterol (12) . However, in the previous study, serum creatinine and creatinine-based GFR were not independent contributors to increased baPWV (24) . In the present study, serum cystatin C had a significant relationship with baPWV independent of other suggested contributors, but serum creatinine and creatinine-based GFR were not the independent variables in multivariate regression analysis. Elastic artery stiffness, resulting in increased PWV, could be an independent cardiovascular risk factor (8) (9) (10) . The baPWV variable used in this study indicates the PWV of a muscular artery and could have not fully represented arterial stiffness. However, because it is well correlated with invasive method of arterial stiffness, baPWV can act as a surrogate of arterial stiffness with some limitations. Thus, the authors suggest that serum cystatin C is an independent determinant of arterial stiffness and factors related with cardiovascular outcome.
When serum cystatin C was excluded from the analysis, age, heart rate, and fasting glucose contributed to increased baPWV in both genders. Waist circumference and serum triglycerides were additional determinants in males. Also, insulin was an additional determinant in females, not in males. In initial baseline characteristics, serum triglycerides, waist circumference, and insulin levels were not different between the both sex groups (male vs. female: triglycerides 130.3 mg/dL vs. 127.8 mg/dL, p= 0.53; waist circumference 84.2 cm vs. 83.8 cm, p= 0.33; insulin 5.43 μIU/mL vs. 5.37 μIU/mL, p= 0.73). These sex-specific findings could not be fully explained using the results of this study, and it was not easy to clarify the relationship between cause and result. In our opinion, the difference in exposure to hormones such as estrogen may leads to the difference of vascular protective mechanisms. The difference in vascular effects according to sex may lead to different statistical results.
In summary, this study confirmed that serum cystatin C is related to PWV even in subjects with normal serum creatinine. This finding suggested that cystatin C could be a more predictable marker of the arterial stiffness than serum creatinine and creatinine-based GFR. 
